Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2021 | The impact of RGn530 in the treatment landscape of Alzheimer’s disease

Jacques Touchon • 10 Mar 2021
AD/PD 2021
Alzheimer’s Disease

Jacques Touchon, MD, PhD, University Hospital of Montpellier, Montpellier, France, details how the RGn530 photobiomodulation medical device could impact the treatment landscape of Alzheimer’s disease, which is a complex and multifactorial disease. Therefore, treatment strategies should target multiple disease aspects, such as amyloid β, tau, and inflammation. Prof. Touchon highlights RGn530’s action on inflammation and adds that this type of therapy could be used in combination with treatments targeting different aspects of the disease. This interview took place during the AD/PD™ 2021 conference.

More from Jacques Touchon

Clinical trial of RGn530 photobiomodulation device on Alzheimer’s disease
6:07
Clinical trial of RGn530 photobiomodulation device on Alzheimer’s disease
Jacques Touchon • 10 Mar 2021

Related Videos

PCSK9-targeted therapies and the risk of stroke and dementia: a meta-analysis of RCTs
3:34
PCSK9-targeted therapies and the risk of stroke and dementia: a meta-analysis of RCTs
Vikash Jaiswal • 26 Aug 2026
How AI and data science are advancing obstructive sleep apnea management
2:23
How AI and data science are advancing obstructive sleep apnea management
Omonigho Michael Bubu • 15 Jun 2026
Obstructive sleep apnea and Alzheimer's disease risk: toward personalized care
5:40
Obstructive sleep apnea and Alzheimer's disease risk: toward personalized care
Omonigho Michael Bubu • 15 Jun 2026
The future of personalized Parkinson's disease care considering differing subtypes
3:10
The future of personalized Parkinson's disease care considering differing subtypes
Massimiliano Passaretti • 28 Jun 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals